You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 9,339,466

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,339,466 protect, and when does it expire?

Patent 9,339,466 protects TPOXX and is included in one NDA.

This patent has thirty-eight patent family members in twenty countries.

Summary for Patent: 9,339,466

Patent landscape, scope, and claims:

Title:	Polymorphic forms of ST-246 and methods of preparation
Abstract:	Polymorph forms of 4-trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocy- cloprop[f]isoindol-2(1H)-yl)-benzamide are disclosed as well as their methods of synthesis and pharmaceutical compositions.
Inventor(s):	Tyavanagimatt; Shanthakumar R. (Corvallis, OR), Stone; Melialani A. C. L. (Corvallis, OR), Weimers; William C. (Corvallis, OR), Nelson; Dylan (Portland, OR), Bolken; Tove' C. (Keizer, OR), Hruby; Dennis E. (Albany, OR), O'Neill; Michael H. (Painesville, OH), Sweetapple; Gary (Madison, OH), McCloughan; Kelley A. (South Haven, MI)
Assignee:	SIGA TECHNOLOGIES, INC. (Corvallis, OR)
Application Number:	13/069,813
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Compound; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,339,466

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Siga Technologies	TPOXX	tecovirimat	CAPSULE;ORAL	208627-001	Jul 13, 2018		RX	Yes	Yes	⤷ Subscribe	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,339,466

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2549871	⤷ Subscribe	122022000033	Germany	⤷ Subscribe
European Patent Office	2549871	⤷ Subscribe	22C1023	France	⤷ Subscribe
African Regional IP Organization (ARIPO)	3221	⤷ Subscribe
Argentina	083435	⤷ Subscribe
Australia	2011232551	⤷ Subscribe
Brazil	112012023743	⤷ Subscribe
Canada	2793533	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.